1/14
08:04 am
MNPR
Monopar Therapeutics (NASDAQ:MNPR) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $104.00 price target on the stock.
Medium
Report
Monopar Therapeutics (NASDAQ:MNPR) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $104.00 price target on the stock.
1/14
05:00 am
MNPR
Rating for MNPR
Medium
Report
Rating for MNPR
1/9
08:00 am
MNPR
Rating for MNPR
Low
Report
Rating for MNPR
1/9
08:00 am
MNPR
Rating for MNPR
Low
Report
Rating for MNPR
1/9
07:00 am
MNPR
Monopar Therapeutics (NASDAQ:MNPR) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Low
Report
Monopar Therapeutics (NASDAQ:MNPR) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
1/9
07:00 am
MNPR
Monopar Therapeutics (NASDAQ:MNPR) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Low
Report
Monopar Therapeutics (NASDAQ:MNPR) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
1/9
05:11 am
MNPR
Monopar Therapeutics initiated with an Overweight at Morgan Stanley
Low
Report
Monopar Therapeutics initiated with an Overweight at Morgan Stanley
1/9
05:11 am
MNPR
Monopar Therapeutics initiated with an Overweight at Morgan Stanley
Low
Report
Monopar Therapeutics initiated with an Overweight at Morgan Stanley
11/14
07:22 am
MNPR
Monopar Therapeutics (NASDAQ:MNPR) was downgraded by analysts at Raymond James Financial, Inc. from a "strong-buy" rating to an "outperform" rating.
High
Report
Monopar Therapeutics (NASDAQ:MNPR) was downgraded by analysts at Raymond James Financial, Inc. from a "strong-buy" rating to an "outperform" rating.
11/14
06:52 am
MNPR
Rating for MNPR
High
Report
Rating for MNPR
11/14
06:52 am
MNPR
Rating for MNPR
High
Report
Rating for MNPR
11/14
06:05 am
MNPR
Monopar downgraded to Outperform from Strong Buy at Raymond James
High
Report
Monopar downgraded to Outperform from Strong Buy at Raymond James
11/14
06:05 am
MNPR
Monopar downgraded to Outperform from Strong Buy at Raymond James
High
Report
Monopar downgraded to Outperform from Strong Buy at Raymond James
11/13
04:14 pm
MNPR
Rating for MNPR
High
Report
Rating for MNPR